Yither biotech

简体中文
img
Your position:
Homepage
>
Product Center
Quadrivalent

Quadrivalent Subunit Influenza Vaccine（0.5ml）

The Quadrivalent Subunit Influenza Vaccine is developed using the company's own patented technology and is in phase III clinical trial. It has the characteristics of high purity and good safety, especially suitable for children. Currently, no such products are available on the market at home and abroad.
Quadrivalent

Quadrivalent Influenza Virus Subunit Vaccine (Adjuvanted)

Trivalent

Trivalent Influenza Virus Subunit Vaccine

Trivalent

Trivalent Influenza Virus Subunit Vaccine (Adjuvanted)

Lyophilized

Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)

23-Valent

23-Valent Pneumococcal Polysaccharide Vaccine

Recombinant

Recombinant Zoster Vaccine (CHO Cell)

Recombinant

Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)

mRNA

mRNA Respiratory Syncytial Virus Vaccine

mRNA

mRNA Broad-Spectrum Poxvirus Vaccine

24-Valent

24-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV24)

Varicella

Varicella Attenuated Live Vaccine

Pre
1
2
E-mail

E-mail

yue.peng@yitherbiotech.com

Whatsapp

Whatsapp

Whatsapp:+86-18521090810

TEL.

+86-021-61639751

TOP

Need more help?

Yither Biotech is striving for and committed to producing innovative and quality vaccines to contribute to the development of China’s biomedical industry and the wellness of Chinese and people around the world.

CONTACT

QUICK LINKS

PRODUCTS

SHARE

Copyright: Yither Biotechnology  Co. Ltd  Powered by:www.30.cn  SEO

Verification 沪ICP备2021028966号-1